Topics 1 - 13 /21
Cancer Death Rate 2008: Breast 25% - Prostate 20% - Lung / Bronchus 20% - Intestine 20% - Stomach 7% - Pancreas 5% - Cerfix - Thyroid - Skin
Men & Women: colon cancer, number two - number three lung cancer. In men, lung cancer caused by smoking causes most deaths
In women, third place - is increasingly lungs - and thyroid cancer - Decreased stomach - Ovarian - and cervical cancer and leukemia
Skin Cancer Facts Most of the more than 1 million cases of non-melanoma skin cancer diagnosed yearly in the United States are considered to be sun-related. Melanoma, the most serious type of skin cancer, will account for about 68,720 cases of skin cancer in 2009 and most (about 8,650) of the 11,590 deaths due to skin cancer each year.
The black skin cancer is the most dangerous types of skin cancer. The ABCDE - usually one can observe the changes in his own skin. A stands for asymmetry, if the spot is deformed. B stands for limits if the limits of the spot is washed out. C stands for coloring - color. D stands for diameter greater than 5 mm. E is for elevation, if the spots grow up. Freckles - freckles - age spots and moles are not dangerous.
Why the war is lost to the cancer? Why should physicians and natural healers to die of cancer? Because the official strategy is wrong in this war.
1. Cancer are not the abnormal cells - there are endogenous microorganisms / parasites that multiply uncontrollably.
2. The cause is a weakened immune system - caused by an acidification of the organism - and an oxygen deficiency.
3. It has been for decades - known - evidence - documented.
4. This is ignored by the official orthodox medicine and the majority of alternative medicine.
5. Their therapies have false bases. That is the reason for the recent defeats in the war against cancer.
There are successful alternative cancer therapies. They strengthen the immune system and fight only tumor cells. They help when the immune system is not completely destroyed. In a war, the losers never tells the truth about the course of the fighting. Therefore, we find no current global cancer statistics. In the following articles you can learn a lot about these issues.
1. What is cancer? " Cancer is a metabolic decompensation " Prof. Dr. Warburg
2. Who gets cancer? When the immune system fails: 1 poor nutrition - 2 Incorrect form of life - 3 Environmental influences
3. How to fight cancer? The immune system to restore them to function.
Nobel Laureate Prof. Dr. Otto Warburg sees as the main cause of cancer, the decreased oxygen concentration in the cell. Quote: "We found experimentally that even a 35% percent reduction is sufficient oxygen breathing to cause such a transformation during cell growth"
Every human being has from birth, a perfect self-healing and protection system, the immune system. It consists of various organs. Each has its specific tasks. The gut this category and is 80% of the greater part of this system. Its surface area exceeding 200 square meters makes it the largest human organ. Its various sections have specific tasks and are not just pipes, held in which only chemical digestive processes. They form a complex bacterial Eco system.
Live in our intestines than 100,000,000,000,000 (trillion) bacteria. That's 14,285,714 x our world population!. According to molecular analysis of 16s ribosomal DNA, is 200 - 300 species at up to 1800 generations, with up to 36,000 species. These creatures not only process food, they produce vitamins, hormones, enzymes, minerals and other substances. This is special and fascinating, that the successful management of this system is not primarily through the brain, but by a so-called abdominal brain
80% of our immune system, these trillions of tiny organisms in our intestines. Any therapy that engages in this Perpetuum Mobile = Eco system and changes is FALSE. These organisms need to live a certain milieu. 2 factors determine that: 1 pH - value 2 Nutrients.
A overacidified environment and malnutrition kill them and thus fail 80% of this protection system. Cancer will develop. The best protection is a largely vegetarian diet, with lots of fiber, adequate minerals, vitamins, enzymes and fats. Who his diet, according to these guidelines consistently surrounded and can not be a functional immune system in most cases, countries once again brought to the function. Anyone who already has cancer, you must perform a gut renovation.
Intestinal rehabilitation = 80% immune restoration in 3 steps:
2007 dead in Germany >> 827 155 humans >> 391 139 men = 47.3 % - 436 016 women = 52,7 %
1. Deaths from heart / circolatory system = 47 % >> 358.683 deaths - 150.472 men = 42 % - 208.211 women = 58 %
Deaths from heart attack >> 61 040 deaths >> 33. 435 men = 55 % - 27. 605 women = 45%
2. Deaths from >> cancer = 25 % >> 211.765 deaths - 113 405 men = 53,5 % / 98 360 women = 46,5 %
men >> 1. colon cancer = 36 312 = 31 % -/ 2. Lung = 30 702 = 27 % 3. Prostate = 12.000 = 10,5 %
Among men, there are two times more people killed by smoking than by prostate cancer
women >> 1. colon cancer = 31 880 = 32,7 % - 2. breast = 16 780 = 17 % - 3. Lung = 12.600 = 13 %
Bowel cancer caused twice as many deaths as breast cancer and smoking
Newly diagnosed cancer patients - world cancer statistics
Entitled "Public Knowledge of Benefits of Breast and Prostate Cancer Screening in Europe" in the Journal of the National Cancer Institute (Vol. 101, published in Issue 17). It began as a collaboration of the Harding Center for Risk Literacy at the Max-Planck-Institute for Educational Research and GfK - Nürnberg e. V.Prof. Dr.Gerd Gigerenzer, Dr. Jutta Mata und Dr. Ronald Frank
Interviews with more than 10,000 people from 9 European countries were received into the first pan-European study to the understanding of cancer screening that the Harding Center for Risk Literacy (Harding Center for Risk competency) together with the Society for Consumer Research (GfK-Nürnberg eV ) conducted. The astonishing results: Europeans prove to be defective informed optimist in terms of early detection - especially the Germans. The Federal Ministry of Health has agreed to strengthen the patient's sovereignty to the "national Gesundheitszie l". But are the citizens of Germany and Europe really informed enough to be able to competently decide? Regarding the knowledge of Europeans for the benefit of cancer screening, the answer certainly is clear: no, they are not.
Prof. Dr. Gerd Gigerenzer, director of the Harding Center for Risk Literacy, the results of the study: "Early detection always carries the risk of damage, as needless surgery or incontinence. To be informed to be able to decide whether they wish to participate or not, must patients to know the potential benefits of early detection as well as to potential Schädigungen.Nach the available scientific studies of the benefits of mammography - screening in the age group of 50 is to 69 years in terms of fatal breast cancer in a reduction by one of per 1,000 women .
Men with PSA screening for prostate cancer - Test and he is close to zero or one in 1,000 men. Our Europe-wide study shows that people are aware of these connections are not easy. If we want to mature patients and no paternalistic health care, then we must start right here. We need - information, particularly in a system increasingly expensive - the people fully and accurately thus enabling them the ability to competently make the necessary decisions. "
Women - Mammography As the group led by Gerd Gigerenzer of the Max Planck Institute for Human Development reported to overestimate, 92 percent of all women questioned the usefulness of mammography as a means of avoiding a fatal disease or breast cancer, they did not quantify. Gigerenzer puts this down to a misleading presentation of study results in the media. There is frequently emphasized the relative risk reduction, absolute value, but not mentioned. A common statement is that mammography reduces the risk of breast cancer by 20 percent. In reality, it is less than one percent. And in the randomized trials, mammography reduced breast cancer mortality of only 5.0 / 1000 to 3.9 / 1000 women aged 40 to 74 years. You â?? rettetâ? less than one thousand women in his life.
Men - PSA test promised 89% percent of all respondents is too much of the PSA test. In Germany, more than half believe that the test 10 to 100 of 1000 men could save lives. In reality, there are less than 1 in 1,000.
75,000 diseases has identified the WHOalsDiagnose Bezeichnungenin the IDC-10. All diseases are encrypted using internationally valid letters and numbers. Also by the expression of the physicians and the clinics for medical bills is incomprehensible. There are called sources and explains technical terms, so that the secret to the world of medicine understands something better The world seems to be super organized medicine. We want something to investigate further.
The WHO has 193 member states. To incorporate the decisions of the WHO.
The United States will begin official use of ICD-10 on October 1, 2013. As Clinical Modification ICD-10-CM for diagnosis coding and Procedure Coding System ICD-10-PCS for inpatient hospital procedure coding.
October 2013 seems a long way away with little need to prepare now for the changes from ICD9 to ICD10 codes but I recently learned the shocking truth. The Healthcare Billing and Management Association held a conference in Boca Raton this month with a session attended by approximately 200 medical billers on the new ICD10 codes. Even though I have looked into the changes and even written on them, I was shocked to hear all that is really involved. We all need to start paying attention now.
My original questions revolved around whether all doctors will be expected to start using ICD10 codes on a specific day and will all the insurance companies be ready to accept them on that same day or will it be more of a transitional thing like the NPI numbers were.
My first surprise was that ICD10 codes are already in effect in all the rest of the world. Other countries have been using them for years. We are way behind the times with regard to the rest of the world.
My second surprise was that ICD9 codes are not just being expanded. ICD10 codes are totally different than ICD9 codes. We won't just add another number and there aren't just a few small changes. ICD10 codes will identify much more information about the visit than ICD9s do. ICD10 codes will contain an expansion of disease classification with greater specificity. They will be much more detailed and will help identify fraudulent billing practices. There will be no 1 to 1 crosswalk. This means that a 309.28 will not equal a A40258Z. You won't take an ICD9 and turn it into an ICD10. They are completely different.
My next thought was how are my doctors going to learn all these codes? We bill many small specialty practices. Many of our chiropractors still do not understand the requirements by Medicare for the ICD9 codes. How are they ever going to get the ICD10 ones right? How are our psychiatrists, psychologists and social workers going to learn ICD10 coding? Most of these are single practitioners who work alone and do not hire a coder.
ICD10 coding will require more clinical information such as "did the patient use tobacco", "did the patient use alcohol", "which finger was cut", "which part of the finger", "was the nail damaged". The new codes will contain alpha characters as well as numeric. The number 1 can mean 15 different things. It is estimated that it will require 24 - 40 hours of classroom education to understand the concepts of ICD10 coding.
Another consideration with the codes now using alpha characters as well as numeric is whether your software will allow you to use alpha characters. If you are using a web based software this won't be a problem, but if you have a server based software, you will want to check with your vendor and make sure you will be able to submit alpha characters in diagnosis codes.
The speaker felt that unspecified codes may be a problem as insurance carriers have yet to tell us if they will pay on unspecified codes with the new changes. Pre-authorization policies will have to be rewritten. Workers comp is not subject to ICD10 changes so some companies say they will not process the ICD10 codes. For a period of time both ICD9 and ICD10 codes will be in effect. Does this sound confusing enough to the average biller yet?
Then came the bombshell. Insurance carriers are not ready for ICD10 codes and most of them won't be ready. Many have announced that they will try to translate the ICD10 code back into an ICD9 code to pay the claim. This means doctors will be translating the ICD9 codes they are familiar with into a new unfamiliar ICD10 code and the insurance carriers will be translating this ICD10 code back into hopefully the same ICD9 code to pay the claim. I can only imagine the problems this will present.
As one of the speakers said "Hold onto your butts! It's going to be a rough ride!"
20.10.2009 / ICD-10-GM 2010: DIMDI publishes final version DIMDI has released the final version of the ICD-10-GM Version 2010 (International Classification of Diseases and Related Health Problems, German Modification) on its website. In the new version were included over 40 proposals from professional societies and professionals from doctors, health insurers and hospitals and more than 100 amendments to the World Health Organization (WHO). The classification forms the basis for the lump-sum payment system G-DRG (German Diagnosis Related Groups). Doctors and information specialists in the hospitals are obliged to diagnoses according to the German Coding (DKR) to encode the body responsible for the G-DRG reimbursement system, self-partner. The encryption is done on the basis of the systematic list of ICD-10-GM. The associated Alphabetical list with its extensive collection of disease names and synonyms makes working with the ICD in practice
Major changes in version 2010, the ICD-10-GM are:
* New encryption for the flu ( "swine flu") established
* Key numbers for blindness and visual impairment revised and rearranged, added to the visual acuity chart
* Appendicitis, Crohn's disease and colitis (colitis) differentiated codable
* New key number for the septic shock
* New key number for HIV disease in pregnancy, childbirth and puerperium
The comment in the introduction of the systematic inventory of important innovations introduced in the various chapters. All changes in detail are included in the update list. The Alphabetical Index to ICD-10-GM 2010 shall be adjusted to the changes in the systematic part and will soon also be published. Download the file reference list for updated editions and ICD-10-GM 2010, you will find as a free PDF files in the Download Center: www.dimdi.de - Specifications - Download Center - ICD-10 GM - Version 2010 - german
Deaths 2007 Germany
ICD-10 1 Death cauases Deaths 2007 men women
Number in % Number % Number %
A00-T98 deaths 827.155. 100,0 391.139 47,3 436.016 52,7
C00-C97 malignant neoplasems 211.765 25,6 113.405 53,6 98.360 46,4
I00-I99 Diseases 358.683 43,4 150.472 42,0 208.211 58,0
I21-I22 Myocardial infarction 61.040 7,4 33.435 54,8 27.605 45,2
J00-J99 Diseases of the respiratory system 57.956 7,0 30.219 52,1 27.737 47,9
K00-K93 Diseases / digestive 42.163 5,1 21. 029 49,9 21.134 50,1
The online database of health reporting (GBE) / Germany, has over one billion numbers and passwords. She has health data and health information from over 100 different sources - including international tables of the OECD - WHO - UN
Tumor markers are proteins or protein components, which can in certain tumors in the blood or other body fluids detected in elevated concentrations. Selection of some important tumor markers:
Each diagnostic method has false positive and false negative results. At a false positive finding of the tumor marker is positive, although there is no tumor. With a false negative result of the finding is negative, although there is a tumor. Both possibilities are found among the vast majority of fatally tumor markers so frequently that the oncology professional societies, the determination of tumor markers for targeted tumor diagnosis (except for very few exceptions) strictly reject! There are some diseases that can lead to an increase in tumor markers, although there is no tumor. In smokers, some of these markers are always elevated, although there is no cancer.
Why did the societies reject the tumor marker screening? Because the probability is too small to detect a tumor in a more well-treatable stage. The benefits are much smaller than the harm that is caused by this.
Tumor markers have an advantage? Only when a particular tumor has occurred, it makes sense to determine the matching or the tumor markers. This is the follow-up
Prostate specific antigen = PSA The prostate makes PSA, which is added to the ejaculate in order to keep it fluid. It is elevated in prostate cancer, but also for other prostate diseases, such as prostatitis or benign prostatic hyperplasia, as it appears in old age is the rule rather than the exception.
Any mechanical stress on the prostate can lead to an increase in PSA. Never the PSA in the blood after a long bike ride decide! This leads inevitably to a suspicion of cancer. The same goes for a rectal examination of the prostate prior to blood collection.
Facts: 1 One in three men over the age of 50 years and will be autopsied after death, has prostate cancer, which did not lead to death, and in most cases not even known. It says: men from 70 am to die, but with the prostate cancer. 2. By screening and cancers are discovered that would have never caused any problems, but lead to the discovery of a complex and burdensome treatment. 3. In the U.S. it is a few years after the nationwide introduction of the PSA test came to a decline in mortality from prostate cancer. 4. In Britain, where the test was hardly done, but there was also a decline. 5. In the United States and Canada were no differences regarding the mortality rate from prostate cancer screening and intensive screening found poor regions. 6. A recent study of 77,000 men in the U.S. showed no benefit of the group with PSA - test. 7. In a European study, a man survived longer, when 1410 men were tested regularly for 9 years
PSA - Test
1. The limit for the PSA in the blood is 4 ng / ml, however, this limit is arbitrary. There are also cases of cancer, and below this value above the value must exist, no cancer. The decrease in value is no all-clear, and the excess is not a death sentence.
2. A value above 4 ng / ml is present in about one third of cases, prostate cancer, at levels above 10 ng / ml in approximately two thirds of the cases.
3. 20% of all prostate cancers are detected at a PSA below 4 ng / ml, nearly half of which is particularly aggressive here would have the test results thus falsely clear.
4. The test is only weak evidence to suggest whether there is a cancer - not how aggressive it is or whether it limits the life expectancy at all.
5. The significance of the PSA test can - especially in the gray area of 4 to 10 ng / ml be increased if the free PSA is determined. If the percentage of free PSA over 20% of total PSA, then the probability of prostate cancer tends to be lower
6. Even more important than the absolute PSA value, the progression of the value seems to be. Increases in a young, healthy man of value within one year from 1 to 3 ng / ml (that is still within the normal range) so it is much more serious than if a more than 70 years with prostate enlargement, the value within 3 years of 3, 5 to 4.2 ng / ml, ie above the normal limit, increases
Successes Chemotherapy = 2,2 % - prostate = 0,0 % - breast cancer = 1,4 % in the journal Clinical Oncology, an article by three Australian teachers appeared with the title: "The Contribution of Cytotoxic Chemotherapy to 5-year Survival in Adult Malignancies". Therein the data of clinical studies with chemotherapy, the last 20 years in Australia and the U.S. are examined. The result is mildly depressing. Although profit 2.3% in Australia and the U.S. only 2.1% of all patients receiving chemotherapy, with respect to the 5-year survival is still cancer patients are still advised to make precisely these therapies.
Overall, the data were analyzed from 72,964 patients in Australia and 154,971 patients in the U.S. who all received chemotherapy. Here, no one can be said, that would indeed be only the data from a few patients and therefore not relevant. The authors rightly ask how it is possible that a therapy that has contributed so little to the survival of patients in the last 20 years, at the same time can be as successful in the sales statistics. It is really hard especially if you remove some types of cancer and look at the successes of the last 20 years.
United States since 1985 with the following cancers 0% progressed: pancreatic cancer - soft tissue sarcoma - Melanoma - Ovarian Cancer - Prostate - Kidney Cancer - Bladder cancer - Brain tumors - multiple myeloma.
Study USA - 23,000 patients>> success: 0% prostate / breast cancer, 1.4% / Prostate O% / 1.0% cancer / stomach cancer 0.7%. And after 20 years of intensive research in the field of chemotherapy and the use of billions of research and donations to the major cancer organizations.
Here are the exact numbers of affected people in Australia and the U.S. statistics the USA and Australia in the original
The U.S. figures show that the fight against cancer is lost. The sources:
Deaths 1971 = 2.995.741 / cancer deaths 1991 = 6.873.628 / 2006 = 11.384.892
cancer deaths 2006 = breast = 2.533.193 / Prostate = 2.177.975 / colon = 1.104.102 / Gynokology = 996.776
Warnings from Dr. JA Muir Gray, Institute of Health Sciences, University of Oxford, England, the head of the British mammography - screening - Program:.
Damage Quote: "All screening screening programs, some may also avail. The damage occurs immediately, it takes longer for the benefits until it is visible. Therefore, the first effect of any program, even if it is a useful, that it overlooks the health of the target verschlechtert.Ein screening program without too many false positives cases in order to be effective. Screening Program - with no false-negative findings caused too much damage to the healthy population. Although irrelevant to the overall population, a single false positive could have disastrous consequences for the individual. "
Even if one assumes that mammography - screening can reduce breast cancer mortality, only very few women have an advantage. Many more women are injured, the majority of women have, at best, no benefit. Whether it can be reduced by screening mammography, the breast cancer mortality in general, remains unclear. The scientific controversy is not resolvable.
Fewer deaths, many women are afraid of breast cancer. Studies show that they often overestimate the risk. Breast cancer is no epidemic. In Germany, dying since the mid-90s, fewer women with breast cancer - a trend that affects all age groups, even those that will be offered for which no screening. An illness of nine women in her life to breast cancer. This information is being read often. She agreed, however, lacks the table: if the woman is 85 years old! Under 40 is against only one of 250 women affected by breast cancer and under 50 years 1 in 60 women. Breast cancer is the cause of death had acquired much rarer than in public: A total of 100 women die from 3 to 4 women with breast cancer, 96 to 97 women die of other causes, especially from cardiovascular disease or other cancers. (Kürzl, R. Dtsch. Ärzteblatt 2004, 101: A 2387-2390 [Heft 36])
"The sooner, the better? "An interview with the doctor and health researcher Dr. Ingrid Mühlhauser University of Hamburg
"One often reads that 30 percent fewer women would die from breast cancer if they regularly went to mammography. That sounds impressive."
"Scientists worldwide are divided on whether mammography can reduce breast cancer mortality really. However, some studies have concluded that because the death rate from breast cancer in the age group between 50 and 69 could be reduced by 20 to 30 percent. What the will mean better understood if one uses the raw data: For every 1,000 women die in ten years without mammography - screening, eight women with breast cancer. The screening would die in the same period, six in 1000 women with breast cancer. six instead of eight women have constructed a reduction of 25 %.
However: in relation to the 1000 women's mammography reduces mortality by only 0.2%. This numerical one has to understand in order to have the benefits of mammography screening for women to be able to really evaluate. The confusing part in the studies is that, although slightly fewer women dying from breast cancer, but that the number of women who die during this period do not total decreases. More women die of other cancers or other causes of death, for example, of a heart attack. "
"For the mammogram, there is a very solid meta analysis from the United States from 2006 / Gøtzsche and Nielsen, which shows that participation for women less likely to die from breast cancer. The German Cancer Aid advertises that women aged 50 to 69 at Participation in this program have up to a 30% breast cancer mortality have. If you look closely at the work, however, we find but very different numbers. The researchers have found seven large studies of mammography, which together had included half a million women. A study was excluded for methodological reasons.
Four studies - albeit with a sub-optimal quality - showed a relative risk for women with mammography of 0.75. This means that women without mammography, an increased from 0.75 to 1.00, ie a 30% have higher risk to die from breast cancer (as is the number of German Cancer Aid reached). If one wants to know how many women die from breast cancer less, can perform the mammography, the risk drops from 1.00 to 0.75, ie only by 25%, not 30%.
It is concealed in the meta analysis of Gøtzsche and Nielsen were two studies - and also the two with the best quality - which showed no statistically significant advantage for the mammogram!
The figures, however, many have still not been made for an adequate assessment. What do we mean by such a risk reduction of 25%? Most certainly think that if 2000 women participating in the program that then 25%, ie 500 less die from breast cancer. That would be convincing indeed. Unfortunately, the reality is different. To really evaluate the results of a study, they may constitute sufficient not only the relative numbers, we must also look at the absolute yet. And they are like:
When participating (2000 women regularly for 10 years!) On mammography screening, then 3 women die of breast cancer.
2000 women did not take part, it will die out 4. This means that relatively flat 25% less. But this means that in absolute terms: 1996 women in the screening did not benefit because they would not die anyway from breast cancer, 3 women did not benefit because they will die from breast cancer despite screening, and ultimately one of 2000 women do benefit. It follows then the high rate of false positive results. If 2000 women participating for ten years on a regular screening, it comes with 200 (!) Women at least once a false positive, ie there is a suspicion placed on a cancer that runs further tests being taken, which in most cases an all-clear result. What physical and emotional stress, this means for the women concerned, I hardly need mention.
1. In 10 of the 200 of the 2,000 women surveyed, there are no suspicious-clear by further diagnosis. These must undergo cancer treatment - and even though there is no cancer as it turns out at the end.
2. The breast cancer mortality among 2000 women is indeed very, very slightly reduced - namely, by 0.05% (this number is not mentioned by the Cancer Aid)! The overall mortality is changing, however, not statistically significant.
3. Mammography has the same radiation exposure as 25 (!) On chest x-rays - and every single mammography, which is taken for the screening, but repeatedly carried out (Vogl. / Hess. Ärztebl, 3 / 2009, 160-166). Like many cancers eventually result from this additional exposure to radiation, is completely unknown
In the whole discussion about breast cancer and mammography, I have not yet heard that might be saved from breast cancer with moderate use of alcohol, avoiding smoking and weight loss in overweight women far more lives through prevention than through the early detection and thus achieve better treatment possibilities for an already existing breast cancer.
Has a normal-weight women, takes less than one drink of alcohol per day and does not smoke and run regularly since youth sports, has a significantly reduced risk for breast cancer. This means that the risk - benefit ratio of a mammogram at her even worse fails, because the same risks faced by the study much less risk by possibly existing breast cancer. Epidemiological studies have shown that women in half with a good vitamin DVersorgung their risk of breast cancer again. "
Professor of Medicine and Community and Family Medicine, Dartmouth Medical School; Co-Director of the White River Junction Outcomes Group. Research Interests:
Dr. Welch is a general internist whose research focuses on the problems created by medicine's efforts to detect disease early: physicians test too often, treat too aggressively and tell too many people that they are sick. Most of his work has focused on overdiagnosis in cancer screening: in particular, screening for melanoma, cervical, breast and prostate cancer. His recent book, "Should I be tested for cancer? Maybe not and here's why" (UC Press 2004) was written while he was a Visiting Scientist at the International Agency for Research on Cancer - the cancer section of the World Health Organization in Lyon, France.
Colorectal cancer is the third most common malignancy worldwide. In Germany, he stands To 1 Body and calls per year, 30,000 dead - 73.000 each year become ill again.
The frequency of colorectal cancer in both sexes is ranked in second place. The insidious thing about cancer is that it often grows in the intestines for years and greater, without causing symptoms. The first signs may be easily confused with other harmless complaints. Discomfort in the stomach - intestine - the area, such as frequent constipation, seizures, or recurrent diarrhea, will always be evaluated by a physician.
Intestinal tumors grow slowly. You can, until finally they cause symptoms that have already been quietly grown a decade. Is found during an examination for a person aged 50 years, a tumor, it can be assumed that its precursor, a so-called intestinal polyps, has been formed as early as age 35 or 40 years.
The main measures for colorectal cancer screening had been 1st The stool test for hidden (occult) blood in the stool and 2 The colonoscopy (colonoscopy). When screening is usually a colonoscopy (colonoscopy done). With this method, also referred to colonoscopy, a tubular endoscope is inserted through the anus into the body. At one end sits a camera through which the doctor can inspect the intestinal wall. In case of suspicion, it can also be found directly from a tissue gripper. A trained doctor as hardly miss a tumor, the number of incorrect diagnoses is also extremely low. So far, non-specific tests on blood in the stool was only about 30% refer to a bowel cancer.
A highly effective test for early detection of colorectal cancer has developed the company Giessen ScheBo Biotech AG. With the new ScheBo ® Tumor M2-PK2 stool test, it is now possible without the presence of blood, highly sensitive and specific to detect colon polyps or intestinal tumors. The test is much cheaper and less expensive. This is only a stool sample is needed. In the important key enzyme for the metabolism of tumor Tumor M2-PK is investigated. An increase is largely cancer-specific. The accuracy of the result can be combined with other parameters continue to increase stool calprotectin as an acute - phase - protein, which has 92% of all colorectal cancers increased values. The test also detects patients with acute - and / or chronic inflammatory disease such as ulcerative colitis and Crohn's disease who are at an increased risk for colon cancer. A large peas stool sample to conduct the testing is sufficient.
Tumor M2-PK detects the metabolic status of various tumors and is a specific enzyme without organ specificity and thus the marker of choice for a variety of tumors. The test is suitable for pre-selection, when it comes to deciding whether it is appropriate for a patient colonoscopy for the diagnosis or exclusion of colorectal tumors. Clinical studies from Germany, England and Ireland, which was tested in the detection of tumor M2-PK in stool as a metabolic biomarker for early diagnosis of colorectal tumors revealed the tumor M2-PK sensitivities of 78 to 97%. This means that of 100 colorectal tumors detected infected persons in the various studies between 78% and 97% of the tumor M2-PK test were. .
Prof. Dr. W. D. Ludwig Anita Petek-Dimmer
Quote from your website on "HPV - Vaccination," "Our medical world of thought has fallen into the patterns of virus / bacteria = disease. Thus, circulating for some years the idea that human papilloma virus (HPV) for the development of cervical cancer (cervical cancer) and genital warts are to blame because it simultaneously in many cases are found in the body of sufferers. However, there are many virologists who question these views strongly.
Since 1992, there are vociferous criticism on this issue, which is however in the rush for a vaccine somewhat in the background. Trigger for this discussion were two molecular biologists from the University of California Berkeley. They noted that there was a lack of consistent HPV DNA sequences and to the relevant HPV gene expression in the tumors that were positive for HPV. Instead, they came to the conclusion that rare spontaneous and chemically induced chromosome - abnormalities that we found in both HPV - DNA-tested positively and negatively with cervical cancer, the cancer had brought about. They prove their investigations so that abnormally dividing cancer cells more vulnerable to infection than normal cells. In addition, research has shown again and again and it is also seen as evidence that viruses are merely indicators of abnormal cellular proliferation and not its cause.
There is as yet no direct causal relationship has been shown, would prove of that is indeed the cause of cervical cancer is by all strains of HPV. Even the NCI, the National Cancer Institute in the U.S., admits this. It is known only that promoting factors such as the long-term use of oral contraceptives ( "the pill") and the number of births as well as genetic changes, smoking, or acquired immune to tumor development. According to official figures are 446,000 new cases of cervical cancer each year occur where 232,000 women die from it. Eighty percent of these cases occur in developing countries. It is expected that more than 70 percent of "sexually active population" at least once in life is to have contact with the HP virus.
In Germany, approximately 8,000 women will become ill, but 80 percent of which healed spontaneously. After a year they are no longer detectable. In Austria and Switzerland disease every year approximately 500 women. To prevent this disease, women are invited to screening. However, it admits that 50 percent can occur all adeno carcinoma, and 25 percent of squamous cell carcinoma of the cervix in women who regularly examine themselves. "
The fact that vaccines can cause side effects, is generally known. But how often they occur and how strong they are, not to mention the official authorities of iron. But since 2001, is the reporting of any suspected case of vaccine complications, there are vague figures. The analysis of data shows the following:
Period 2001-2007 - 287 reported cases of permanent damage - 190 reported deaths due to vaccinations. However, since the reporting rate is estimated only between 5% and 20%, this could mean that: Every year up to 3000 people die (probably much longer) in vaccines! The Paul - Ehrlich - Department denied these estimates do not! Except for 3 new vaccines, there are no studies that challenge the effectiveness of even close. The exceptions are Gardasil, Zostavax (both against cervical cancer) and Cervavix (against shingles). - As seen here from the studies?
Each study included approximately 20,000 subjects in each case, the unvaccinated inoculated into three test groups (/ / scheingeimpft) were divided. However, the studies included for cervical cancer, only a period of 4 years. And cervical cancer develops within more than 20 years. 20,000 each that none of the subjects, whether vaccinated or not, suffered from cervical cancer, only confirms the fact that these studies did not produce any meaningful results. These studies are not so meaningful! Strange: The data of the studies were not released. However, this is not the biggest problem with the new vaccines. The most serious is the fact that all three substances contain substances such as aluminum and formaldehyde. These substances are highly toxic! They are present in almost all the vaccines and injected the patient, and that, although there is no official reason for the mixing of poisons.
Professor Ate van der Zee in the Netherlands, the newly elected President of the European Society of Gynecological Oncology ESGO quotes: "Our most recent treatments consider the fact that all women are different and that it is not enough to try to simply the life expectancy improve. We must also try to keep the impact of treatment on work and family life of a woman as low as possible and as also consider whether they still want to have children. "
"We have also learned how important it is to concentrate our expertise in specialized competence centers, especially for the treatment of rare forms of abdominal cancer, so women have access to the latest know-how and expertise have designed for the treatment of abdominal cancer-trained doctors."
"In developing this expertise we can ensure the same time ensure that new discoveries from the labs found throughout Europe, most effective in clinical treatment and we are developing more sophisticated treatment methods that are focused on the unique genetic and other characteristics of our patients."
How a woman responds to such statements? Women were not previously regarded as fully satisfying?
Nobel Laureate Professor Harald zur Hausen, urgently calls for increased vaccination against HPV infections in order to be able to eradicate the virus?!
At the end of his lecture, Dr. Principle said zur Hausen, that would be a both boys and girls inclusive, universal vaccination program against the human papilloma virus HPV eradication of the virus and thus lead to a virtual disappearance of cervical cancer.
Professor zur Hausen, who was honored in 2008 for the discovery of the HPV virus as a cause of cervical cancer with the Nobel Prize for Medicine, said that even if the HPV screening mainly affects women's health, they certainly also have important implications for male health had: "If we want to achieve eradication within a reasonable time frame, we need to vaccinate both sexes, and the research shows that boys develop in the same way as girls react to the vaccine. The main risk for an HPV infection to cancer to the women wear, and because of the cost of vaccination was decided to begin the vaccination of girls. But other cancers that may be associated with anal HPV infection, for example - or mouth cancer are more common in men and genital warts occur in both sexes. It So there are good reasons for boys before the start of sexual maturity vaccinate them, "said Professor zur Hausen.
High-dose folic acid and vitamin B preparations increase uterine cancer risk women, folic acid, vitamin B2, B6 or B12 in the form of supplements in higher intake levels, may increase the risk for uterine cancer, so the research findings at the of 11 to 14 October 2009 in Belgrade, Serbia, held on duty 16th International Conference of the European Society of Gynecological Oncology (ESGO) were presented. The results of a twenty-year follow-up study on the dietary habits of 23,000 at the Iowa Women's Health Study participating in post-menopausal women, showed that women who took large quantities of these drugs to himself, twice as often a uterine cancer type II developed as female, a normal dosage took. However, showed no effect on the uterine cancer type I
Dr. S Uccella by the department of gynecologic surgery at the Mayo Clinic in Rochester, USA, said that these results run counter to the expected protective effect of the supplements and that further investigations showed that an intake of folic acid from 200 to 600 mcg / day quite a protective effects have, higher doses increased the sizes of the order of 1000 mcg / day, however, the risk for uterine cancer. He concluded that these findings in countries like the U.S. and Canada, which would be attached to folic acid and vitamin B preparations foods, and countries that were considering similar measures, could have an impact on the health of women.
The main cause is the smoke It contains around 2,000 substances, of which at least 100 carcinogen (carcinogenic) (for example, tar and) a variety of other hydrocarbon compounds. It has been demonstrated that tobacco smoke contains benzo (a) pyrene, known as tumor suppressor p53 may cause harm. Also the products resulting from the combustion of oxygen radicals are probably involved in the pathogenesis of lung cancer. 95 percent of all patients with lung cancer are smokers. Passive smoking also been shown to increase the disease risk. 30 to 40 years after the start of smoking, the risk of illness is up to 60-fold higher than in nonsmokers. The so-called British Doctors Study already occupied in the 1950s, the relationship between lung cancer and smoking.
Genetic studies of lung tissue showed that the activity of genes that are responsible for the repair of DNA and to stop the development of lung cancer, is permanently reduced, even in former smokers.
The second most common cause of lung cancer is the radioactive gas radon. In Germany there are approximately 1,900 lung cancer deaths each year attributable to exposure to radon. He also radioactive radon decay products separate out during inhalation into the bronchial tubes and accumulate there. Irradiate the tissue with very biologically active alpha particles. In some regions of Germany, among other things in eastern Bavaria, Saxony and Thuringia and in Breisgau, it is recommended that the basement gas-tight seal, as rises through the rock radon. The World Health Organization has set a target level of 100 becquerels per cubic meter of air. In Switzerland, radon is considered to be sources of ten percent of all Bronchialkarzinomfälle
Other toxic substances such as asbestos, uranium, chromium compounds, mustard gas, nickel and polycyclic aromatic hydrocarbons are also considered to be carcinogenic. This increases the risk of a disease is many times when the patient is also smoking. If exposure to asbestos, for example, increases the risk of disease of nonsmokers by five times, with smokers around the Neunzigfache. A family history suggests a genetic component. Chronic inflammatory irritation also have an effect on the development of lung cancer. You can also arise in the lungs of old scars, which occur after tuberculosis, silicosis, or pulmonary infarction .. In uranium miners, lung cancer is a recognized occupational disease.
As related diet and lung cancer / lung cancer could under the EPIC study is recorded since 1992 at over 500,000 initially healthy participants from ten European countries, the eating behavior. In addition, weight, height and body fat distribution of participants will be registered and blood tests performed. For 15 years, all new-onset cancers and other chronic diseases are recorded and associated with the dietary habits and lifestyle. Over the years, it could be obtained more knowledge about the composition of a healthy diet, which could offer a potential protection against cancer and other diseases.
In April 2007 researchers took the study centers at the German Cancer Research Center in Heidelberg and at the German Institute for Nutrition Research (DIFE) in Potsdam-Rehbrücke Result: A high fruit - and vegetable consumption protects against lung cancer and cancer of the upper digestive tract. Above all, men with lower consumption benefit from an increase to 300 g of fruit and vegetables a day.
When you smoke cigarettes, cigars and pipe tobacco, a distinction between the mainstream smoke (HS) and sidestream (NS). The main stream smoke produced by combustion at 700 ° to 900 ° C in the corona zone of the cigarette under the influence of large amounts of oxygen through the train is inhaled by the smoker, and this largely. The sidestream smoke is formed in the same area at lower heat (400 to 600 ° C) and oxygen depletion during the Zugpause. It happens only in small quantities of the filter of the cigarette. From the different conditions during combustion results in two very different mixtures. We distinguish the gaseous phase with volatile substances such as benzene, vinyl chloride or acrolein and the particulate phase, the tar, in which the semi-and non-volatile substances such as alkaloids (including nicotine), aromatic amines or polycyclic hydrocarbons (PAHs) are located.
It is estimated the total number of existing connections on up to 12 000, with more than 4 000 compounds were isolated and identified. Among them there are organ-specific carcinogens, Cocancerogene, as well as promoters and inhibitors of tumorigenesis. Some of the major carcinogens in the HS and LS are shown in Table 1. The environmental tobacco smoke (ETS), that tobacco smoke in indoor air, which is charged to approximately 85% of NS and composed 15% of exhaled HS, not just the passive smokers, but also the Rau-cher itself, although the NS, the carcinogens result of incomplete combustion of up to 130 times the concentration of the HS contains, is the inclusion of hazardous substances by the rapid dilution in the air and through the aging process significantly lower than in smokers. The assessment of the hazard potential of the ETS is difficult and controversial;
Cancerogene in smoke
" Cancer is a metabolic decompensation "
That is a hypothesis for the development of cancer of Nobel Laureate Otto Heinrich Warburg (1883-1970) In his observations on cancer cells, he put down an unusually high lactate levels. Lactic acid is a typical fermentation product. Warburg discovered that cancer cells have a different energy metabolism than normal cells. During his research, he decoded the mechanism of cellular respiration and found the process for this important enzyme, cytochrome - oxidase. In power plants of cells, the mitochondria, it is responsible for transferring electrons to oxygen which is converted to water here. Cell respiration provides much of the energy that the cell needs to live. For these basic biochemical discoveries Warburg was awarded in 1931, the Nobel Prize in Medicine.
Warburg had developed in 1924 these observations a hypothesis for the development of cancer. This means that cancer cells prefer their energy from the anaerobic fermentation (glycolysis) of glucose and therefore attract oxygen was not necessary for cancer growth. He proved that cancer cells carry a metabolism in the mitochondria without oxygen utilization. A disturbance of mitochondrial function in cancer cells is the main reason for the occurrence of cancer. Cancer cells were mainly ferment glucose and do not burn. Warburg observed that tumor cells gain their energy mainly from a metabolic process known as fermentation, and not as healthy body cells, from cell respiration. Eating sugary foods, while the fight against cancer, thereby reducing the chances of survival. Chemically, the following happens: Large amounts of refined sugar or starch in the diet, the effect in the body, a peak in blood glucose levels. Result, the body releases insulin to keep the peak value of blood glucose under control. Fed the high blood sugar but primarily tumors, because of their changed metabolism.
In the course of cellular respiration, the sugar scaffold is further reduced. It was only for this complete breakdown, which is known as the respiratory chain and be held responsible for energy production in the mitochondria, oxygen is needed. Healthy cells make just to lack of oxygen on fermentation. The cells fall into untrained muscles as oxygen deficiency, when they are suddenly claiming it again. The body reacts with muscle soreness, because lactic acid produced during fermentation. Cancer cells evade the cellular respiration, even if they have enough oxygen is available
2005 The findings of the German cancer researcher Dr. John Coy first clarify the basis for the Warburg - Effect on. After Dr. Coy already during his work at the German Cancer Research Center in Heidelberg at the TKTL1-met gene, followed by 2005, the detection of the enzyme TKTL1 (transketolase-like-1), which is responsible for the fermentation of glucose for energy supply to the tumor cell. TKTL1 through the activation of the enzyme in cancer cells they are in a position to win then energy from glucose, unless there is enough oxygen for combustion of glucose present.
Dr. Coy Quote: had the importance of metabolism TKTL1 "In my research at the German Cancer Research Center (DKFZ) in Heidelberg, I discovered a new gene that I because of its similarity to already known genes Transketolase Transketolase-like-1 (transketolase-like - 1) was called - short TKTL1. Some years later I was able to investigate in connection with my previous research, whether the item I discovered gene plays a role in relation to cancer. Thus I discovered that all of the cancers examined by me the TKTL1 gene was activated, there may be dependent on the patient but also in non-activated state. With the help of an antibody for the first time I was able to prove the TKTL1 protein. So I had provided proof that the gene actually TKTL1 can form a protein. As a result of different research groups have been numerous studies conducted with these antibodies, which should reveal the importance of TKTL1. The results are impressive: It has been shown that cancer patients have TKTL1 protein in the tumor have a significantly worse survival compared to patients without TKTL1.
At the same time my discovery of the theory of Otto Warburg, the German Nobel Prize in Medicine in 1931 has confirmed. He stood in 1924 on the hypothesis that the problem is cancer in the shutdown of the combustion and the turning of sugar fermentation. This transition corresponds to the transition from negative to TKTL1-TKTL1-positive cell. Once the TKTL1 metabolism is activated, the survival rate deteriorated dramatically for cancer patients
Why this is so, or what makes TKTL1 cells so dangerous? A milestone in the research transketolase - like-1 was the elucidation of the metabolism. I was able to show that is produced by cleavage of glucose with the help of TKTL1 lactic acid. Lactic acid is excreted from the cell and thus promotes two key processes: The lactic acid destroys surrounding healthy tissue, so that the tumor can grow unchecked and the conditions for invasion and metastasis are present. On the other lactic acid is a kind of protective - fewer immune cells come closer to the tumor to destroy it. "
Meanwhile, many international research groups have recognized the potential of TKTL1 and study results from around the world, such as U.S., China, Australia and South Africa, confirm the importance of TKTL1. The influence of TKTL1 metabolism and inhibiting the enzyme TKLT1 is considered an extremely promising approach to cancer treatment. Renowned scientists such as Nobel Prize winner Watson are calling for a rethinking of cancer research, with emphasis on the underlying biochemical metabolic processes of the disease
The John Hopkins institution in the United States TKTL1 identified the gene as one of the most important precursors of cancer genes (proto-oncogenes), thus confirming the essential involvement of TKTL1 in the development of aggressive cancers. Also study results of the renowned German Cancer Research Center (DKFZ) in Heidelberg TKTL1 demonstrate the importance of the enzyme for rapid cell growth and viability of human cancer cells, and thus the danger of cancer.
2006, a work by researchers at the University of Jena and the German Institute of Human Nutrition Potsdam was published - Rehbrücke, and the Charité in Berlin, which supports the Warburg hypothesis. In their work, the researchers in a form of colon cancer in experimental animals have shown that a forced aerobic combustion of glucose, inhibits cancer growth. They sat this one, the protein frataxin, which smuggles them with the help of genetic engineering in mitochondria. In a second experiment, they promoted the anaerobic fermentation of glucose are reversed and set an increased tumor growth. The interesting thing about the experiments of Prof. Ristow and colleagues was that the cancer cells showed a significantly lower growth when the mitochondria in their energy balance improved
Conventional medicine sees the genes that control mechanisms in tumor growth and cell function. The reality is exactly the opposite. Mitochondria control the genes. These are subordinated to the mitochondria. Without boosting the mitochondria of the tumor will continue to grow. Should first be sought after due to a chronic infection. Without their treatment does not improve the immune system. See also the work of Prof. Dr. Lill
© klaus j zupan - picture “ two trees two friends “